(October 26, 2016, 1:47 PM EDT) -- SILVER SPRING, Md. — The Food and Drug Administration on Oct. 24 said it approved classwide labeling changes for all prescription testosterone products and anabolic androgenic steroids (AAS) to warn about...
New Testosterone, Steroid Labels To Warn Of Abuse, Dependence, FDA Says In Warning
To view the full article, register now.
Try for FREE for fourteen days
Already a subscriber? Click here to login